Telomir Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Sep 2025Filed 10/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 14/05/2026 | Sep 2024Filed 10/11/2025 | Jun 2024Filed 10/11/2025 | Mar 2024Filed 10/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$1.7 | −$1 | −$1.1 | −$5.1 | −$2.2 | −$6 | −$1.4 | −$6.3 | |
| −$0.79 | −$0.03 | −$0.03 | −$0.17 | −$0.07 | −$0.20 | $0.05 | −$0.23 | |
| 61 | 34 | 32 | 30 | 30 | 30 | 30 | 29 |
Trend